North Shore University Hospital, Department of Infectious Disease — Manhasset, New York

North Shore University Hospital, Department of Infectious Disease is a clinical research site located in Manhasset, New York, United States 11030.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

North Shore University Hospital, Department of Infectious Disease has participated in 1 clinical trials.

Therapeutic areas: HIV Infections.

Sponsors: ViiV Healthcare.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Manhasset

Browse all research sites in New York · View every site in Manhasset

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Shore University Hospital, Department of Infectious Disease?

North Shore University Hospital, Department of Infectious Disease has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Shore University Hospital, Department of Infectious Disease conducted?

North Shore University Hospital, Department of Infectious Disease has 1 clinical trials on record. Their work covers HIV Infections.

Is North Shore University Hospital, Department of Infectious Disease accredited by Crixeo Clinical Trials?

North Shore University Hospital, Department of Infectious Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Shore University Hospital, Department of Infectious Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.